• Webinar Details

  • Home / Learn / Live CE / Live CE Event Calendar / Webinar Details


A Year in Review: New Drugs and Drug News of 2021

Event Type

Live Online

Date

Wednesday, August 24, 2022

Time

8:00 PM - 9:15 PM ET

Location

PharmCon Webinar Studio (freeCE.com)

Credits

1.25 Contact Hour(s)

Target Audience

Nurse, Pharmacist, Pharmacy Technician

Cost

$30.00

  • Overview

    While much of the industry’s attention in 2021 was focused on FDA decisions about COVID vaccines and related therapies, a total of 50 new drugs were approved in 2021, outpacing the 10-year average for FDA drug approvals. This session provides a broad overview of the drugs approved in 2021, which includes significant growth in monoclonal antibody approvals. This session is designed to be a cursory overview of new approvals, bringing forward the most actionable and relevant pieces for those practicing in today’s pharmacies. The session includes a look at the COVID related emergency use authorizations and approvals introduced in 2021 and reviews some of the more controversial decisions and challenges of the year.

    Handouts

    Slide Document:   22080L01_2pp.pdf


    Slide Document:   22080L01_6pp.pdf

    Financial Support By

    PharmCon
  • Nurse

    Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2021.
    Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.
    For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy.


    Pharmacist

    Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2021.
    Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.
    For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy.


    Pharmacy Technician

    Recognize the approved indication, common adverse effects and drug interactions for new drugs approved by the FDA in 2021.
    Identify important drug alerts by the FDA (Public Health Advisories) and implications for patient care.
    For selected new medications approved in 2021, identify the burden-to-benefit ratio of therapy.

  • Repeat Presentation

    This presentation was last given on Wednesday, July 6, 2022

    Future Airings

    DateTime 
    Tuesday, October 4, 20229:00 PMView
    Tuesday, December 6, 202210:30 AMView

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-22-080-L01-N

    Pharmacist 0798-0000-22-080-L01-P

    Pharmacy Technician 0798-0000-22-080-L01-T

    ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

 

©2015 PharmCon All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.